Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,209,280 papers from all fields of science
Search
Sign In
Create Free Account
Bone Marrow Suppression
Known as:
suppression, bone marrow
A condition in which the production of red blood cells, white blood cells, and/or platelets by bone marrow stem cells is inhibited, usually as a side…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Bone Marrow
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The Sabotaging Role of Myeloid Cells in Anti‐Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia
Chunyan Li
,
Tao Liu
,
A. Bazhin
,
Yuhui Yang
Journal of Cellular Physiology
2017
Corpus ID: 21098448
Tumor angiogenesis has become a promising target for anti‐tumor therapy. Unfortunately, the somewhat inevitable occurrence of…
Expand
2014
2014
Treatment of bullous pemphigoid with low‐dose oral cyclophosphamide: a case series of 20 patients
A. Gual
,
P. Iranzo
,
J. Mascaró Jr.
Journal of the European Academy of Dermatology…
2014
Corpus ID: 21016994
Cyclophosphamide has been commonly used for the treatment of pemphigus vulgaris and mucous membrane pemphigoid with satisfactory…
Expand
2013
2013
Attenuation of Plasmodium Berghei berghei -induced Bone Marrow Suppression by Bark Extract and fractions of Chrysophyllum albidum on bone marrow response to haemolytic conditions in male albino mice
E. Adewoye
,
A. Salami
,
A. Jagun
2013
Corpus ID: 35395323
Chrysophyllum albidum is a tropical plant in Southern Nigeria. Methanol extract of Chrysophyllum albidum bark ( MeCaB ) has been…
Expand
2013
2013
Experimental Research of the Impacts of Shenxian Mixture on the Bone Marrow Suppression and Thrombopoietin in Cyclophosphamide Model Mice
Luan Rong-lan
2013
Corpus ID: 76552964
Objective To study the impacts of shenxian mixture on the bone marrow suppression and thrombopoietin(TPO)in cyclophosphamide…
Expand
2000
2000
Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
N. Tung
,
R. Berkowitz
,
+5 authors
S. Cannistra
Gynecologic Oncology
2000
Corpus ID: 24700264
OBJECTIVES The goal of this study was to determine the maximally tolerated doses (MTDs) of carboplatin, paclitaxel (Taxol…
Expand
1989
1989
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
Q. L. Wang
Zhonghua zhong liu za zhi [Chinese journal of…
1989
Corpus ID: 5864848
236 patients with various advanced malignant solid tumors treated by combined chemotherapy with routine doses of cisplatin (DDP…
Expand
1978
1978
Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
S. Davis
,
Y. K. Park
Cancer treatment reports
1978
Corpus ID: 27467200
Fifty-four patients with clinical evidence of residual colorectal adenocarcinoma following surgical removal of the primary tumor…
Expand
1978
1978
Clinical Management of Marrow Suppression and Immune Suppression
J. Lokich
1978
Corpus ID: 68485377
Marrow suppression and immune suppression commonly accompany cancer. They are most frequently observed in the leukemias and other…
Expand
1976
1976
Effect of Bone Marrow Suppression on Granulocyte Opsonin Levels 1
B. Andersen
,
K. M. Debelak-Fehir
,
R. Epstein
Proceedings of the Society for Experimental…
1976
Corpus ID: 23218035
Summary Levels of serum opsonin for neutrophilic granulocytes were measured in dogs made neutropenic by cyclophosphamide…
Expand
1976
1976
The Effects of Leucogenenol On Benzene Induced Bone Marrow Suppression In Rabbits
Joseph Francis Talluto
1976
Corpus ID: 92619771
Procedure. The white blood cell counts of rabbits were depressed to 1500 ± 500 cells per cubic millimeter by the action of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required